Patient
SITE004-0017
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE004 (DEU) (Dr. Tanaka)
consented 2025-09-07
Adverse events
4
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-08-31 (study day 162); relationship: not assessed
Grade 4 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-07-28 (study day 128); relationship: not assessed; serious criteria: life-threatening
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-04-30 (study day 39); relationship: NOT RELATED
Grade 2 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-04-23 (study day 32); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.